Commercials for drugs associated with akathisia routinely fail to mention the word.

Patient information leaflets may list symptoms, like restlessness and agitation, but, still fail to clearly communicate that these symptoms may be signs of akathisia.

Our latest public health video spotlights this glaring gap in risk communication. Read our press release about “Let’s Call It What It Is: Akathisia” at https://www.einpresswire.com/article/918176838/missd-releases-new-public-health-video-on-medication-induced-suicide-risk.

Together, let’s make akathisia a household word.